Overview

Definition:
-Left hepatectomy is a major surgical procedure involving the removal of the left lobe of the liver
-The left lobe comprises segments I (caudate lobe, though sometimes considered separate), II, III, and IV according to Couinaud classification
-This procedure is indicated for a variety of benign and malignant conditions affecting this portion of the liver.
Epidemiology:
-The incidence of left hepatectomy is lower than that of right hepatectomy, reflecting the distribution of liver pathology
-It is more commonly performed for tumors arising from the left lobe, such as hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma, or liver metastases, as well as for certain benign lesions like adenomas or large hemangiomas that cannot be managed otherwise.
Clinical Significance:
-Left hepatectomy is a critical intervention for treating localized liver disease within the left lobe
-Successful execution requires a deep understanding of liver anatomy, vascular supply, and biliary drainage, as well as careful perioperative management to minimize morbidity and mortality
-It is a procedure that significantly impacts patient survival and quality of life when indicated for oncological indications.

Indications

Malignant Tumors:
-Hepatocellular carcinoma (HCC) confined to the left lobe
-Intrahepatic cholangiocarcinoma involving the left lobe
-Liver metastases from colorectal, neuroendocrine, or other primaries located predominantly in the left lobe and amenable to complete resection.
Benign Lesions:
-Large or symptomatic hepatic adenomas in the left lobe
-Giant or symptomatic hemangiomas in the left lobe
-Congenital cysts or other rare benign lesions requiring resection.
Other Conditions:
-Selected cases of liver trauma involving the left lobe
-Management of hepatic artery pseudoaneurysm or arteriovenous malformations within the left lobe
-Focal suppurative disease in the left lobe not responding to conservative management.

Preoperative Preparation

Patient Evaluation:
-Comprehensive assessment of liver function (Child-Pugh score, MELD score)
-Evaluation of tumor resectability and extent
-Assessment of future remnant liver function and volume
-Thorough cardiopulmonary evaluation.
Imaging Studies:
-Contrast-enhanced CT scan (arterial, portal venous, delayed phases) for tumor staging, vascular anatomy, and future remnant liver volume calculation
-MRI for better soft tissue characterization and vascular assessment
-Chest X-ray and CT chest for metastatic workup
-Doppler ultrasonography for vascular assessment.
Nutritional Support:
-Optimization of nutritional status
-Administration of high-protein, low-sodium diet
-Vitamin and mineral supplementation as required.
Medical Optimization:
-Management of ascites, encephalopathy, and coagulopathy
-Prophylaxis against infections, particularly in patients with cirrhosis
-Blood product availability and cross-matching.

Procedure Steps

Surgical Approach:
-Open laparotomy (subcostal or Mercedes-Benz incision) or laparoscopic approach
-Choice depends on surgeon expertise, patient factors, and tumor characteristics.
Liver Mobilization:
-Dissection of the falciform ligament, left triangular ligament, and hepatogastric ligament to mobilize the left lobe
-Identification and preservation of the inferior vena cava and suprahepatic veins.
Vascular Control:
-Careful identification and ligation or division of the left portal vein and left hepatic artery
-Mobilization and control of the left hepatic vein before its entry into the suprahepatic inferior vena cava.
Biliary Dissection:
-Identification and division of the left hepatic duct
-If the confluence is involved, a more extensive resection or reconstruction may be necessary
-Meticulous hemostasis is paramount throughout the procedure.
Transection:
-Division of the liver parenchyma using an ultrasonic dissector, cavitron ultrasonic surgical aspirator (CUSA), harmonic scalpel, or electrocautery, following the planned resection margin
-Careful identification and control of smaller vessels and bile ducts within the parenchyma.

Postoperative Care

Monitoring:
-Close monitoring of vital signs, fluid balance, and urine output in an intensive care unit (ICU) setting
-Serial assessment of abdominal girth and presence of ascites.
Pain Management:
-Effective analgesia using patient-controlled analgesia (PCA) or epidural anesthesia
-Early mobilization to prevent deep vein thrombosis (DVT) and pulmonary complications.
Fluid And Electrolyte Balance:
-Intravenous fluid management guided by hemodynamic parameters and urine output
-Monitoring and correction of electrolyte imbalances, particularly potassium and sodium.
Nutritional Support:
-Initiation of enteral feeding as soon as bowel function returns
-parenteral nutrition may be required in select cases
-Monitoring for signs of malnutrition.
Complication Surveillance:
-Vigilant monitoring for early complications such as hemorrhage, bile leak, sepsis, hepatic insufficiency, and pulmonary issues
-Regular laboratory investigations including liver function tests, coagulation profile, and electrolytes.

Complications

Early Complications:
-Hemorrhage from the resection surface or major vessels
-Bile leak from the cut surface or hepatic ducts (biloma)
-Hepatic insufficiency (acute liver failure), characterized by jaundice, coagulopathy, and encephalopathy
-Sepsis
-Wound infection
-Pneumonia
-Acute kidney injury
-Postoperative ileus.
Late Complications:
-Biliary strictures leading to secondary biliary cirrhosis
-Recurrence of malignancy
-Incisional hernia
-Chronic liver disease progression if underlying cirrhosis is present
-Portal hypertension complications.
Prevention Strategies:
-Meticulous surgical technique with precise vascular and biliary control
-Adequate future remnant liver volume calculation and preservation
-Prophylactic antibiotics
-Early mobilization and pulmonary hygiene
-Judicious use of blood products
-Careful fluid management
-Close postoperative monitoring.

Prognosis

Factors Affecting Prognosis:
-Histological type of tumor
-Stage of malignancy
-Completeness of resection (R0 resection)
-Underlying liver function (presence of cirrhosis)
-Patient's general health status
-Development of postoperative complications
-Experience of the surgical team.
Outcomes:
-For malignant conditions, successful R0 resection can offer the best chance of long-term survival and cure
-For benign conditions, the goal is symptomatic relief and prevention of complications
-The overall survival depends heavily on the underlying pathology.
Follow Up:
-Regular follow-up appointments with imaging (CT/MRI) and laboratory tests to monitor for tumor recurrence or disease progression
-For benign conditions, follow-up is aimed at monitoring for any late complications or recurrence of symptoms.

Key Points

Exam Focus:
-Understand the anatomical segments of the left liver lobe (II, III, IV, and potentially I)
-Recall the major vessels and ducts supplying and draining these segments
-Differentiate indications for left vs
-right hepatectomy
-Recognize key complications like bile leak and hepatic insufficiency.
Clinical Pearls:
-Accurate preoperative assessment of future remnant liver volume is crucial to prevent postoperative hepatic failure
-Intraoperative ultrasound can aid in precise tumor localization and vascular structure identification
-Careful hemostasis and identification of aberrant vessels are vital.
Common Mistakes:
-Underestimation of remnant liver volume leading to insufficient future liver remnant
-Inadequate control of the left hepatic vein or artery resulting in uncontrollable bleeding
-Failure to identify accessory bile ducts leading to bile leaks
-Not adequately addressing perioperative coagulopathy.